Search company, investor...

Predict your next investment

Plum Alley company logo
Venture Capital
FINANCE | Investment Firms & Funds
plumalley.co

Investments

28

Portfolio Exits

2

About Plum Alley

Plum Alley Investments is a venture firm investing in early-stage, high-growth technology and healthcare companies with at least one woman founder from the STEM fields. Plum Alley invests in advanced technologies and medical breakthroughs disrupting huge markets and driving exponential value for people, the planet, markets, and the economy.

Headquarters Location

43 West 23rd Street

New York, New York, 10010,

United States

347-348-7901

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Expert Collections containing Plum Alley

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Plum Alley in 1 Expert Collection, including E-Commerce.

E

E-Commerce

10,549 items

Companies that sell goods online (B2C), or enable the selling of goods online via tech solutions (B2B).

Latest Plum Alley News

Juvena Therapeutics Raises $41M in Series A Funding

Nov 8, 2022

Juvena Therapeutics , a Redwood City, CA-based biotechnology company, raised $41M in Series A funding. The round was led by Mubadala Capital and Horizons Ventures, with participation from Bison Ventures, Manta Ray Ventures, IRONGREY, Alumni Ventures, Plum Alley, Jeff Dean, Transform VC, Karl Pfleger, BoxOne Ventures, Intersect VC, Compound, and Felicis. The company intends to use the funds for the expansion of its drug discovery platform and advance its biologics pipeline targeting chronic and age-related diseases. Co-founded by Dr. Hanadie Yousef, and Dr. Jeremy O’Connell, Juvena Therapeutics is a biotech company accelerating the development of therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has been under-leveraged due to the complexity of identifying and screening such proteins. The company is developing a patent-pending computational drug discovery and development platform that is delivering novel biologics to address major unmet medical needs in chronic and age-related diseases by mining regenerative proteins secreted by stem cells. As the company expands its platform, it is also accelerating its preclinical programs, having secured funding from the California Institute of Regenerative Medicine and the National Institute of Health for the treatment of Myotonic Dystrophy Type 1, a rare disease that is incurable today. FinSMEs 08/11/2022

Plum Alley Investments

28 Investments

Plum Alley has made 28 investments. Their latest investment was in Juvena Therapeutics as part of their Series A on November 11, 2022.

CBI Logo

Plum Alley Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/8/2022

Series A

Juvena Therapeutics

$41M

Yes

7

9/7/2022

Series A - II

Gameto

$17M

No

3

4/28/2022

Series B

Ashvattha Therapeutics

$69M

Yes

1

1/10/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

11/19/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/8/2022

9/7/2022

4/28/2022

1/10/2022

11/19/2021

Round

Series A

Series A - II

Series B

Series A

Series A

Company

Juvena Therapeutics

Gameto

Ashvattha Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$41M

$17M

$69M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

3

1

10

10

Plum Alley Portfolio Exits

2 Portfolio Exits

Plum Alley has 2 portfolio exits. Their latest portfolio exit was Tinkergarten on April 04, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/4/2023

Acquired

$99M

3

8/24/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/4/2023

8/24/2020

Exit

Acquired

Acquired

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

3

10

Plum Alley Team

3 Team Members

Plum Alley has 3 team members, including current Founder, Chief Executive Officer, Deborah B Jackson.

Name

Work History

Title

Status

Deborah B Jackson

Shattuck Hammond Partners, and Goldman Sachs

Founder, Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Deborah B Jackson

Subscribe to see more

Subscribe to see more

Work History

Shattuck Hammond Partners, and Goldman Sachs

Title

Founder, Chief Executive Officer

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Compare Plum Alley to Competitors

D
Discovery Ventures

Discovery Ventures is a healthcare venture capital fund. The firm seeks to invest in the health tech, gene therapy, bionics, stem cells, nanotechnology, and biotechnology sectors. It was founded in 1998 and is based in Wilmington, Delaware.

D
DBL Partners

DBL Partners is a venture capital firm that invests in the cleantech, information technology, sustainable products and services, and healthcare sectors to deliver venture capital returns and enable social, environmental, and economic benefits. It was founded in 2002 and is based in San Francisco, California.

SyndicateRoom Logo
SyndicateRoom

SyndicateRoom is an online equity crowdfunding platform that allows its members to co-invest in exciting companies with seasoned investors.

General Catalyst Logo
General Catalyst

General Catalyst is a venture capital firm that makes early-stage and transformational investments. It back entrepreneurs who are building technology companies and businesses, and invests in seed-stage, early-stage, later-stage, and growth-stage companies operating in consumer, enterprise, fintech, crypto, health assurance, software, transportation, big data, and technology sectors. The company was founded in 2000 and is based in Cambridge, Massachusetts.

L
Lightspeed Venture Partners

Lightspeed Venture Partners operates as an early-stage venture capital firm. It focuses on accelerating disruptive innovations and trends in the enterprise and consumer sectors. It was founded in 2000 and is based in Menlo Park, California.

Sequoia Capital Logo
Sequoia Capital

Sequoia is a venture capital firm. It seeks to invest in companies operating in the information technology, healthcare, manufacturing, mobile, nanotechnology, financial service, internet, energy, media, and retail sectors. The company was founded in 1972 and is based in Menlo Park, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.